ANXA1 and small cell lung carcinoma: In another study conducted by the same authors [57], a different panel of 7 autoantibodies (p53, NY-ESO-1, CAGE, GBU4-5, Annexin 1, SOX2 and HuD) had a sensitivity of 50% and specificity of 99% in detecting SCLC patients.